Zobrazeno 1 - 10
of 119
pro vyhledávání: '"Kirsty J McLean"'
Autor:
Hannah F Collins, Rebekka Biedendieck, Helen K Leech, Michael Gray, Jorge C Escalante-Semerena, Kirsty J McLean, Andrew W Munro, Stephen E J Rigby, Martin J Warren, Andrew D Lawrence
Publikováno v:
PLoS ONE, Vol 8, Iss 2, p e55708 (2013)
Despite the extensive study of the biosynthesis of the complex molecule B12 (cobalamin), the mechanism by which the lower ligand 5,6-dimethylbenzimidazole (DMB) is formed has remained something of a mystery. However, recent work has identified and ch
Externí odkaz:
https://doaj.org/article/bfd765d7e8924914a5f57c87c6186900
Autor:
Joshua B Parsons, Andrew D Lawrence, Kirsty J McLean, Andrew W Munro, Stephen E J Rigby, Martin J Warren
Publikováno v:
PLoS ONE, Vol 5, Iss 11, p e14009 (2010)
PduS is a corrin reductase and is required for the reactivation of the cobalamin-dependent diol dehydratase. It is one component encoded within the large propanediol utilisation (pdu) operon, which is responsible for the catabolism of 1,2-propanediol
Externí odkaz:
https://doaj.org/article/1e6943e3077c4ed7bda8efdc8c1e4271
Autor:
Dr. Safaa M. Kishk, Dr. Kirsty J. McLean, Dr. Sakshi Sood, Darren Smith, Jack W.D. Evans, Prof. Mohamed A. Helal, Prof. Mohamed S. Gomaa, Prof. Ismail Salama, Prof. Samia M. Mostafa, Dr. Luiz Pedro S. de Carvalho, Colin W. Levy, Prof. Andrew W. Munro, Dr. Claire Simons
Publikováno v:
ChemistryOpen, Vol 8, Iss 7, Pp 995-1011 (2019)
Abstract The emergence of untreatable drug‐resistant strains of Mycobacterium tuberculosis is a major public health problem worldwide, and the identification of new efficient treatments is urgently needed. Mycobacterium tuberculosis cytochrome P450
Externí odkaz:
https://doaj.org/article/3aae741715394bd2a5f6041ac6a202cf
Autor:
Mark A. Ashworth, Elvira Bombino, René M. de Jong, Hein J. Wijma, Dick B. Janssen, Kirsty J. McLean, Andrew W. Munro
Publikováno v:
ACS Catalysis, 12(24), 15028-15044. AMER CHEMICAL SOC
CYP105AS1 is a cytochrome P450 from Amycolatopsis orientalis that catalyzes monooxygenation of compactin to 6-epi-pravastatin. For fermentative production of the cholesterol-lowering drug pravastatin, the stereoselectivity of the enzyme needs to be i
Autor:
George J. Baker, Hazel M. Girvan, Sarah Matthews, Kirsty J. McLean, Marina Golovanova, Timothy N. Waltham, Stephen E. J. Rigby, David R. Nelson, Richard T. Blankley, Andrew W. Munro
Publikováno v:
ACS Omega, Vol 2, Iss 8, Pp 4705-4724 (2017)
Externí odkaz:
https://doaj.org/article/9d2e711fc5a24b71bb75ed933c0f3c61
Autor:
Mona M. Katariya, Matthew Snee, Richard B. Tunnicliffe, Madeline E. Kavanagh, Helena I. M. Boshoff, Cecilia N. Amadi, Colin W. Levy, Andrew W. Munro, Chris Abell, David Leys, Anthony G. Coyne, Kirsty J. McLean
Funder: Division of Intramural Research, National Institute of Allergy and Infectious Diseases; Id: http://dx.doi.org/10.13039/100006492
Funder: Cambridge Trust; Id: http://dx.doi.org/10.13039/501100003343
Mycobacterium tuberculosis (Mtb) w
Funder: Cambridge Trust; Id: http://dx.doi.org/10.13039/501100003343
Mycobacterium tuberculosis (Mtb) w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::139d9139a1ac4d5afba661d0322e8c46
https://www.repository.cam.ac.uk/handle/1810/347549
https://www.repository.cam.ac.uk/handle/1810/347549
Autor:
Martyn Frederickson, Irwin R. Selvam, Dimitrios Evangelopoulos, Kirsty J. McLean, Mona M. Katariya, Richard B. Tunnicliffe, Bethany Campbell, Madeline E. Kavanagh, Sitthivut Charoensutthivarakul, Richard T. Blankley, Colin W. Levy, Luiz Pedro S. de Carvalho, David Leys, Andrew W. Munro, Anthony G. Coyne, Chris Abell
Publikováno v:
Frederickson, M, Selvam, I R, Evangelopoulos, D, McLean, K J, Katariya, M M, Tunnicliffe, R B, Campbell, B, Kavanagh, M E, Charoensutthivarakul, S, Blankley, R T, Levy, C W, de Carvalho, L P S, Leys, D, Munro, A W, Coyne, A G & Abell, C 2022, ' A new strategy for hit generation: Novel in cellulo active inhibitors of CYP121A1 from Mycobacterium tuberculosis via a combined X-ray crystallographic and phenotypic screening approach (XP screen) ', European Journal of Medicinal Chemistry, vol. 230, 114105 . https://doi.org/10.1016/j.ejmech.2022.114105
There is a pressing need for new drugs against tuberculosis (TB) to combat the growing resistance to current antituberculars. Herein a novel strategy is described for hit generation against promising TB targets involving X-ray crystallographic screen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6d9c2705833bafc4766f5cadaceb345
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 11380, p 11380 (2021)
International Journal of Molecular Sciences
International Journal of Molecular Sciences
CYP102A1 (BM3) is a catalytically self-sufficient flavocytochrome fusion protein isolated from Bacillus megaterium, which displays similar metabolic capabilities to many drug-metabolizing human P450 isoforms. BM3′s high catalytic efficiency, ease o
Autor:
Craig A. Hutton, Harshwardhan Poddar, James A. Triccas, Kirsty J. McLean, Gayathri Nagalingam, Andrew W. Munro, Sunnia Rajput, Irwin Selvam, Colin Levy
Publikováno v:
Journal of Medicinal Chemistry. 62:9792-9805
A series of analogues of cyclo(l-tyrosyl-l-tyrosine), the substrate of the Mycobacterium tuberculosis enzyme CYP121, have been synthesized and analyzed by UV-vis and electron paramagnetic resonance spectroscopy and by X-ray crystallography. The intro
Publikováno v:
Journal of Raman Spectroscopy. 49:287-297
Cytochrome P450 BM3 is an important model system for mammalian P450s and has great potential for biotechnological applications owing to its high catalytic activity, facilitated by its fused diflavin reductase domain. Mutagenesis studies have shown th